- Home
- IMRN vs IMNN Comparison
IMRN vs IMNN Comparison
Compare IMRN & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- IMNN
- Stock Information
- Founded
- IMRN 1994
- IMNN 1982
- Country
- IMRN Australia
- IMNN United States
- Employees
- IMRN N/A
- IMNN N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- IMRN Health Care
- IMNN Health Care
- Exchange
- IMRN Nasdaq
- IMNN Nasdaq
- Market Cap
- IMRN 15.0M
- IMNN 15.1M
- IPO Year
- IMRN N/A
- IMNN 1985
- Fundamental
- Price
- IMRN $2.32
- IMNN $1.02
- Analyst Decision
- IMRN Strong Buy
- IMNN Strong Buy
- Analyst Count
- IMRN 1
- IMNN 2
- Target Price
- IMRN $5.00
- IMNN $21.50
- AVG Volume (30 Days)
- IMRN 6.0K
- IMNN 245.4K
- Earning Date
- IMRN 10-15-2024
- IMNN 11-12-2024
- Dividend Yield
- IMRN N/A
- IMNN N/A
- EPS Growth
- IMRN N/A
- IMNN N/A
- EPS
- IMRN N/A
- IMNN N/A
- Revenue
- IMRN $3,271,194.00
- IMNN N/A
- Revenue This Year
- IMRN N/A
- IMNN N/A
- Revenue Next Year
- IMRN N/A
- IMNN N/A
- P/E Ratio
- IMRN N/A
- IMNN N/A
- Revenue Growth
- IMRN 171.67
- IMNN N/A
- 52 Week Low
- IMRN $1.48
- IMNN $0.48
- 52 Week High
- IMRN $5.96
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- IMRN 33.24
- IMNN 45.16
- Support Level
- IMRN $2.66
- IMNN $0.99
- Resistance Level
- IMRN $2.87
- IMNN $1.08
- Average True Range (ATR)
- IMRN 0.13
- IMNN 0.07
- MACD
- IMRN -0.03
- IMNN 0.00
- Stochastic Oscillator
- IMRN 16.74
- IMNN 26.92
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.